; (III) the National Institute of Allergy and Infectious Diseases; (IV) the National Heart, Lung, and Blood Institute; (V) the National Institute of Neurological Disorders and Stroke; (VI) the National Library of Medicine; and (VII) such other national research institutes and national centers as may be appropriate, as determined by the Director of the National Institutes of Health. (B) Additional members In addition to the designees under subparagraph (A), the Council may include such other designees from Federal departments or agencies as the Chairperson of the Council deems appropriate. (C) Designation A person appointed to the Council as a designee shall be a senior official or employee of the department or agency whose responsibilities and subject matter expertise are relevant to the Council’s objectives listed in subsection (b), as determined by the designating official. (d) Strategic plan; reports (1) Strategic Federal Plan to Improve Diagnosis in Health Care Not later than 18 months after the date of enactment of this Act, the Council shall develop, submit to the Secretary and Congress, and make publicly available a strategic plan, to be known as the Strategic Federal Plan to Improve Diagnosis, that, consistent with the objectives listed in subsection (b)— (A) identifies coordinated opportunities to enhance scientific research and reduce systemic barriers in order to improve diagnosis in health care; and (B) includes legislative and administrative policy recommendations. (2) Reports to Congress Not later than July 31 of every odd-numbered year beginning with the first such year after the date of submission of the first Strategic Federal Plan to Improve Diagnosis under paragraph (1), the Council shall prepare, submit to the Secretary and Congress, and make publicly available an updated Strategic Federal Plan to Improve Diagnosis that includes— (A) such updates as the Council determines to be appropriate